Advertisement

PharmacoEconomics & Outcomes News

, Volume 820, Issue 1, pp 27–27 | Cite as

Reclassification of triptans as pharmacy-only cost effective

Clinical study
  • 3 Downloads

Reference

  1. Parkinson B, et al. Cost Effectiveness of Reclassifying Triptans in Australia: Application of an Economic Evaluation Approach to Regulatory Decisions. Internet Document : 24 Dec 2018. Available from: URL: https://doi.org/10.1016/j.jval.2018.09.2840

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations